Neurology® Podcast cover image

Patient Perceptions of FDA Approval; Part 3 of the Thunderclap Headache Series

Neurology® Podcast

00:00

Do You Think Patients Understand the Risks Associated With Adi Canmab?

The story of adi canmab is still playing out in the news, so i wanted to just get your thoughts a little bit more about it. I think we all certainly want a disease modifying treatment for patients with a simers disease. So now we have a drug that's been fda approved. But i guess my question is, do you think patients understand what that means? That's a great point. The subtleties in these debates, at times hinge on very specialized knowledge. And this is where our responsibiliti as a group of specialists really come to the fore in trying to help protect patients who are perhaps most vulnerable because they lack good options.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app